Hearing Loss Trial, Completed NCT05270876 Sponsor: Cochlear Condition: Hearing Loss
Back to Hearing Loss

Trial results

AI generated results summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

According to the results reported on ClinicalTrials.gov, this trial enrolled 20 participants, and all 20 completed the study — none dropped out. The trial was looking at two different methods of fitting (adjusting and setting up) cochlear implants or hearing devices, comparing a standard fitting method against a newer, novel fitting method. The main thing being measured was how well participants could correctly identify single-syllable words in a quiet environment under each method. The reported data shows that there was a difference of 3.8 percentage points in the scores between the two fitting methods, with the standard method and the novel method producing slightly different results on the word recognition test. To put that simply: on average, participants' scores for correctly identifying spoken words in quiet differed by 3.8 percentage points depending on which fitting method was used. No other outcome measures were included in the submitted results data, so no further figures are available to describe. These are the results as reported to ClinicalTrials.gov. They are not medical advice — always discuss what they mean for you with your doctor.

These are the results as reported to ClinicalTrials.gov, not medical advice. Verify independently with the trial site and discuss what they mean for you with your doctor.

Hearing Loss Trial, Completed

NCT05270876
Completed Not Applicable 🇦🇺 Australian site

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You use a CE-approved Nucleus brand cochlear implant that allows you to understand spoken words without lip-reading.
  • You have been using your cochlear implant for at least three months.
  • You are 18 years of age or older at the time you enter the study.
  • You are fluent in the language that will be used during the study tests.
  • You are able to understand speech well enough to complete the study tasks, as decided by the study doctor.
  • You are willing and able to sign a written consent form agreeing to take part.

Who may not be able to join:

  • You are unable or unwilling to follow the requirements of the study, as decided by the study doctor.
  • You have other health conditions that the study doctor believes would prevent or limit you from taking part in the hearing tests.
  • You work at the study site and are directly involved in running this study, or you are the spouse, parent, child, or sibling of someone who is.
  • You are an employee of Cochlear (the company running the study) or of any organisation hired by Cochlear to help run this study.
  • You are currently taking part in, or have taken part in within the last 30 days, another clinical trial involving an experimental drug or medical device.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Australian sites

HEARnet Clinical Studies - The University of Melbourne, Carlton, Victoria
Cochlear Ltd. Melbourne, East Melbourne, Victoria

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Completed
Phase
Not Applicable
Sponsor
Cochlear
Registry
ClinicalTrials.gov
Start date
19 October 2020
Est. completion
6 March 2023

Where this trial is recruiting

🇦🇺 Australia 🇧🇪 Belgium

2 site(s) in Australia. Confirm current status and contact details directly with the trial site.

Primary endpoints

Mean Difference Between Standard and Novel Fitting Method for Monosyllabic Word Scores in Quiet

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov